Skip to main content

Olukotun Adeoye Y

In the past year, 2 open-market sale filings worth $850.5K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$850.5K
2 filings
Net
−$850.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Olukotun Adeoye Y as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ARWR Arrowhead Pharmaceuticals, Inc.

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 20, 2026 (view filing)5:25 PM ETAug 182 daysOlukotun Adeoye YDirectorSSale−2.00K$86.96−$173.9K−6.0%31.6K after
Dec 23, 2025 (view filing)Dec 194 daysOlukotun Adeoye YDirectorSSale−10.0K$67.66−$676.6K−22.9%33.6K after3 lots10b5-1
Jan 27, 2025 (view filing)Jan 234 daysOlukotun Adeoye YDirectorSSale−959$21.00−$20.1K−2.6%35.8K after10b5-1
Dec 30, 2024 (view filing)Dec 273 daysOlukotun Adeoye YDirectorSSale−2.85K$20.00−$57.0K−7.2%36.7K after10b5-1
Mar 6, 2023 (view filing)Mar 33 daysOlukotun Adeoye YDirectorSSale−11.3K$32.65−$370.6K−59.1%7.87K after
Jan 4, 2022 (view filing)Jan 31 dayOlukotun Adeoye YDirectorSSale−4.05K$64.75−$262.2K−45.0%4.95K after3 lots
Sep 14, 2021 (view filing)Sep 131 dayOlukotun Adeoye YDirectorSSale−5.00K$63.76−$318.8K−35.7%9.00K after2 lots